Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Regulatory News (TILS)

  • There is currently no data for TILS

PRG Nutraceuticals UK Launch

1 Oct 2009 10:34

RNS Number : 0408A
ReGen Therapeutics PLC
01 October 2009
 



1 October 2009

For immediate release

ReGen Announces PRG Nutraceuticals Limited UK Launch

ReGen Therapeutics Plc ('ReGen' or the 'Company') is pleased to announce that it has been notified by PRG Nutraceuticals Limited that it has launched Colostrinin™* as 'MemoryAid' in the UK.

Announcing the launch, PRG Managing Director Dr Peter Garrod said:-

"Every day we hear more evidence of how the population faces a terrible future as our brains become increasingly affected by conditions associated with getting old. MemoryAid contains a complex that we believe will help people to fight the onset of the problems that result from our brains undergoing the normal ageing process. Many years of research into the complex has shown that it promotes antioxidant activity, can reduce the toxicity of beta amyloid and protects the brain against the damaging effects of free radicals, all of which manifest themselves in the problems that occur as our brains naturally age. The complex has also been shown to increase the average lifespan of living cells and reduces premature ageing, which will also benefit consumers.

MemoryAid is targeted at a wide spectrum of people, both the older community, who may already be noticing that their brains are not functioning in the manner they are normally accustomed to, and at younger adults, who just want to protect themselves against memory deterioration in the future.

We are very excited by the benefits of MemoryAid and believe that it has a bright future on everyone's breakfast table."

MemoryAid is available on the internet at www.memoryaid.com or by contacting PRG on 01580 891349 or mobile 07785 740421.  

MemoryAid

Support for healthy brain ageing

Maintains normal mental function and supports healthy brain ageing.

Increases the average lifespan of living cells.

Reduces the aggregation and toxicity of beta amyloid, a feature of neurodegenerative conditions.

Protects the brain against the damaging effects of many free radicals

*Colostrinin™ is a proline-rich polypeptide complex that maintains normal mental function and supports healthy brain ageing.

For further information:

Dr Peter Garrod

PRG Nutraceuticals Ltd

Tel. 01580 891349 / 07785 740421

Percy Lomax ReGen Therapeutics Plc Tel No 020 7153 4920

Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel No 020 7628 3396

Nick Bealer/David Scott Alexander David Tel No 020 7448 9820 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGCBDGIDGGGCB
Date   Source Headline
11th Oct 20071:34 pmRNSHolding(s) in Company
1st Oct 20077:01 amRNSProduct Launch
20th Sep 20077:00 amRNSInterim Results
19th Sep 20077:02 amRNSChange of Adviser
23rd Aug 20077:00 amRNSResearch Update
21st Aug 200711:59 amRNSHolding(s) in Company
10th Aug 200711:52 amRNSHolding(s) in Company
1st Aug 20077:01 amRNSWebsite Compliance
16th Jul 20077:01 amRNSRe Contract
29th Jun 20077:02 amRNSTotal Voting Rights
21st Jun 200712:18 pmRNSHolding(s) in Company
20th Jun 20071:29 pmRNSHolding(s) in Company
14th Jun 20071:34 pmRNSIssue of Equity
11th Jun 20077:01 amRNSResearch Update
15th May 20071:00 pmRNSAGM Statement
15th May 200712:00 pmRNSAGM Statement
24th Apr 20074:44 pmRNSNotice of AGM
19th Apr 200710:01 amRNSHolding(s) in Company
19th Apr 200710:00 amRNSHolding(s) in Company
19th Mar 20077:03 amRNSFinal Results
28th Feb 20076:17 pmRNSTotal Voting Rights
14th Feb 20074:37 pmRNSHolding(s) in Company
14th Feb 20074:34 pmRNSHolding(s) in Company
14th Feb 20074:33 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:34 pmRNSHolding(s) in Company
12th Feb 20074:30 pmRNSHolding(s) in Company
6th Feb 20077:01 amRNSIssue of Equity
5th Feb 20077:01 amRNSResearch Update
2nd Feb 20071:33 pmRNSHolding(s) in Company
15th Jan 20074:39 pmRNSHolding(s) in Company
20th Dec 200611:19 amRNSTotal Voting Rights
15th Dec 20064:39 pmRNSHolding(s) in Company
12th Dec 20066:33 pmRNSDirector/PDMR Shareholding
11th Dec 20061:14 pmRNS5th Annual City Presentation
7th Dec 200611:00 amRNSResearch Update
5th Dec 20066:18 pmRNSDirector/PDMR Shareholding
26th Sep 200611:59 amRNSEGM Statement
26th Sep 20068:00 amRNSInterim Results
1st Sep 20063:19 pmRNSNotice of EGM
25th Aug 20067:00 amRNSResearch Update
17th Aug 200610:35 amRNSChange of Adviser
21st Jul 20067:00 amRNSIssue of Equity
14th Jul 20065:38 pmRNSTrading Statement
13th Jul 20067:01 amRNSLicence Agreement
4th Jul 200610:19 amRNSResponse to press comment
13th Jun 200611:57 amRNSAGM Statement
22nd May 200611:11 amRNSResearch Update
19th May 20067:00 amRNSNotice of AGM
12th May 20067:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.